GA
SLRN

General Atlantic’s ACELYRIN SLRN Stock Holding History

General Atlantic’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,695,327
Closed -$6.66M – 17
2025
Q1 		$6.66M Hold
2,695,327
– – 0.22% 12
2024
Q4 		$8.46M Sell
2,695,327
-194,341
-7% -$941K 0.3% 13
2024
Q3 		$14.2M Hold
2,889,668
– – 0.41% 15
2024
Q2 		$12.7M Hold
2,889,668
– – 0.4% 15
2024
Q1 		$19.5M Hold
2,889,668
– – 0.45% 18
2023
Q4 		$21.6M Hold
2,889,668
– – 0.31% 22
2023
Q3 		$29.4M Buy
2,889,668
+1,389,668
+93% +$29.5M 0.45% 21
2023
Q2 		$31.4M Buy
+1,500,000
New +$30.7M 0.49% 22

Other funds holding SLRN

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

General Atlantic's SLRN Position: Q2 2025 in Review

General Atlantic sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 2,695,327 shares — an estimated $6.66M sold.

General Atlantic first reported a position in SLRN in Q2 2023 and held it in 8 quarters. The position peaked at $31.4M in Q2 2023. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • General Atlantic reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • General Atlantic sold 2,695,327 ACELYRIN shares in Q2 2025, an estimated $6.66M.
  • General Atlantic first reported a position in ACELYRIN in Q2 2023 and held it in 8 quarters.
  • General Atlantic's ACELYRIN position peaked at $31.4M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on General Atlantic's 13F filing for Q2 2025, filed 14 Aug 2025.